Estrogen fights urinary infection in mouse study
(Medical Xpress)—Estrogen levels drop dramatically in menopause, a time when the risk of urinary tract infections increases significantly.
Jan 23, 2013
0
0
(Medical Xpress)—Estrogen levels drop dramatically in menopause, a time when the risk of urinary tract infections increases significantly.
Jan 23, 2013
0
0
Scientists at The Scripps Research Institute (TSRI) have performed successful tests of an experimental methamphetamine vaccine on rats. Vaccinated animals that received the drug were largely protected from typical signs of ...
Nov 1, 2012
1
0
(Medical Xpress)—Researchers at Stanford University have developed a procedure that reduces a fear response in mice. It involves, team lead Asya Rolls said as she presented the groups' findings at this year's meeting of ...
For decades before antibiotics became generally available, sunshine was used to treat tuberculosis, with patients often being sent to Swiss clinics to soak up the sun's healing rays. Now, for the first time scientists have ...
Sep 3, 2012
0
0
Cancers are notorious for secreting chemicals that confuse the immune system and thwarting biological defenses.
Jul 15, 2012
0
0
Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could paradoxically shorten treatment time for the highly contagious lung infection according to new research from ...
Jun 28, 2012
0
0
A small inherited change in DNA is largely responsible for overactivating a gene linked to poor treatment response in people with acute leukemia.
May 25, 2012
0
0
The goal of cancer treatment is to match the right drug to the right target in the right patient. But before such "personalized" drugs can be developed, more knowledge is needed about specific genomic alterations in cancers ...
Mar 28, 2012
0
0
Patient prognosis and treatment response prediction are key factors in treating ovarian cancer, which is characterized by the lowest survival rate among gynecological cancers. Consequently, there is strong demand for a more ...
Apr 15, 2024
0
0
SYNC-T, an investigational therapy that combines a device-induced vaccination at the tumor site with intratumoral infusion of a multitarget biologic drug led to numerous clinical responses in patients with metastatic castrate-resistant ...
Apr 8, 2024
0
0